Agteria Biotech, a company focused on cutting global greenhouse gas emissions by 1 per cent, has secured €6M in a seed round of funding.

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report) today and set a price target ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) recently disclosed updates to the employment agreements of key executive officers in a Form 8-K filing dated February 1, 2025. The company entered into ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...